Mesa Laboratories, Inc. (MLAB)
| Market Cap | 1.61B |
| Revenue (ttm) | 138.92M |
| Net Income (ttm) | 4.05M |
| Shares Out | 5.15M |
| EPS (ttm) | 0.77 |
| PE Ratio | 401.20 |
| Forward PE | 35.21 |
| Dividend | $0.64 (0.21%) |
| Ex-Dividend Date | Nov 29, 2021 |
| Volume | 44,919 |
| Open | 309.03 |
| Previous Close | 309.20 |
| Day's Range | 307.27 - 313.95 |
| 52-Week Range | 232.59 - 325.50 |
| Beta | 0.31 |
| Analysts | Hold |
| Price Target | 320.00 (+3.3%) |
| Est. Earnings Date | Nov 4, 2021 |
About MLAB
Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products in the United States, Europe, Asia, North America, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the den...
Financial Performance
In 2020, MLAB's revenue was $133.94 million, an increase of 13.81% compared to the previous year's $117.69 million. Earnings were $3.27 million, an increase of 84.14%.
Financial StatementsAnalyst Forecast
According to 5 analysts, the average rating for MLAB stock is "Hold." The 12-month stock price forecast is 320.00, which is an increase of 3.32% from the latest price.
News
Bull of the Day: Mesa Laboratories (MLAB)
Key M&A boosts sales & EPS, opens path to new business with Clinical Genomics Division
Mesa Labs Declares Quarterly Dividend
Lakewood, Colo., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarter...
Mesa Labs (MLAB) Moves 4.5% Higher: Will This Strength Last?
Mesa Labs (MLAB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.
LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical qualit...
Mesa Labs (MLAB) Lags Q1 Earnings Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -5.88% and 2.41%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Announces First Quarter Results
LAKEWOOD, Colo., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today reported results for its first fiscal quarter (“1Q22”).
Analysts Estimate Mesa Labs (MLAB) to Report a Decline in Earnings: What to Look Out for
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., July 06, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular qu...
New Strong Sell Stocks for June 14th
CPB, MLAB, TMQ, CGAU, and BHVN have been added to the Zacks Rank #5 (Strong Sell) List on June 14, 2021
Mesa Laboratories: Q4 Earnings Insights
Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98, which beat the estimate of ...
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
LAKEWOOD, Colo., June 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q21”) and full year ended March 31, 2021 (“FY21”).
Mesa Labs (MLAB) to Report Q4 Results: Wall Street Expects Earnings Growth
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
7 Small-Cap Stocks To Buy for Their Big Ambitions
These seven small-cap stocks have the potential of rebounding and making it big in the post-pandemic reality of 2021. The post 7 Small-Cap Stocks To Buy for Their Big Ambitions appeared first on Investo...
Mesa Labs (MLAB) Lags Q3 Earnings Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -0.68% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Reports Third Quarter Results for FY21
LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020.
Mesa Labs (MLAB) Earnings Expected to Grow: What to Know Ahead of Q3 Release
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mesa Labs Declares Quarterly Dividend
LAKEWOOD, Colo., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular qu...
Mesa Labs (MLAB) Q2 Earnings and Revenues Beat Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of 78.50% and 5.25%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Reports Second Quarter Results for FY21
LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.
Earnings Preview: Mesa Labs (MLAB) Q2 Earnings Expected to Decline
Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MESA LABS DECLARES QUARTERLY DIVIDEND
LAKEWOOD, Colo., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular qu...
Bear of the Day: Mesa Labs (MLAB)
Bear of the Day: Mesa Labs (MLAB)
3 Stocks Growing Revenue Per Share Fast
The S&P 500 index saw its trailing 12-month revenue per share increase by approximately 4% every year over the past five years.
Mesa Labs (MLAB) Misses Q1 Earnings and Revenue Estimates
Mesa Labs (MLAB) delivered earnings and revenue surprises of -6.18% and -5.55%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Mesa Labs Reports First Quarter Results
LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”).